Document is current
Any future updates will be listed below
-
Authors
Nunes, Sophia
Hessey, Erin
Dorais, Marc
Perreault, Sylvie
Jouvet, Philippe
Phan, Véronique
Lacroix, Jacques
Lafrance, Jean-Philippe
Samuel, Susan
Zappitelli, Michael
-
Funding
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé
Hospital for Sick Children
- License Information
-
More Information
Article History
Received: 26 October 2020
Revised: 18 January 2021
Accepted: 10 February 2021
First Online: 26 March 2021
Declarations
:
: Dr. Michael Zappitelli is a consultant for an AKI biomarker study with Bioporto. Inc., Chair of Safety Review Board for Eloxx Pharmaceuticals Inc. (completed) and co-Chair of Data Safety and Monitoring Board for Cytopheryx Inc.
